Although the exact prevalence of post-COVID-19 condition (also known as long COVID) is
unknown, more than a third of patients with COVID-19 develop symptoms that persist for …

As the world transitions from the acute phase of the COVID-19 pandemic, a novel concern
has arisen—interstitial lung disease (ILD) as a consequence of SARS-CoV-2 infection. This …

Prolonged lung pathology has been associated with COVID-19, yet the cellular and
molecular mechanisms behind this chronic inflammatory disease are poorly understood. In …

Objectives Previous studies suggested that coronavirus disease 2019 (COVID-19) could
lead to pulmonary fibrosis, but the incidence of newly diagnosed interstitial lung disease …

The role of immunity in the pathogenesis of various pulmonary diseases, particularly
interstitial lung diseases (ILDs), is being increasingly appreciated as mechanistic …

Abstract Coronavirus disease-2019 (COVID-19) may severely affect respiratory function and
evolve to life-threatening hypoxia. The clinical experience led to the implementation of …

Considering the significant burden of post-acute COVID-19 conditions among patients
infected with SARS-CoV-2, we aimed to identify the risk of acute respiratory complications or …

On the March 11, 2020, the World Health Organization (WHO) declared the outbreak of
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as a global pandemic …

Introduction Many patients with interstitial lung diseases (ILDs), especially fibrotic ILDs,
experience chronic cough. It negatively impacts both physical and psychological well-being …

Introduction Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial pneumonia marked by
progressive lung fibrosis and a poor prognosis. Recent studies have highlighted the …